Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1975 2
1977 2
1978 3
1981 1
1982 1
1983 2
1986 1
1988 2
1991 2
1992 1
1993 1
1994 1
1996 1
1997 1
1999 2
2000 1
2001 1
2005 1
2008 3
2009 2
2010 8
2011 6
2012 11
2013 12
2014 7
2015 11
2016 3
2017 6
2018 10
2019 6
2020 14
2021 14
2022 14
2023 10
2024 20
2025 23
2026 14

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

197 results

Results by year

Filters applied: . Clear all
Page 1
ONO-4578 Plus Nivolumab in Unresectable Advanced or Recurrent Gastric or Gastroesophageal Junction Cancer.
Kawazoe A, Yamaguchi K, Hamaguchi T, Narita Y, Boku S, Oshima T, Hara H, Hamamoto Y, Ishido K, Esaki T, Hosaka H, Yasui H, Koeda K, Nishina T, Tsuji Y, Fukagawa T, Goto M, Oki E, Sugimoto N, Matsuoka H, Yokoyama F, Yoshida T, Yoshida K, Oshima Y, Iwasa S. Kawazoe A, et al. Among authors: boku s. Cancer Sci. 2025 Sep;116(9):2523-2536. doi: 10.1111/cas.70130. Epub 2025 Jul 6. Cancer Sci. 2025. PMID: 40618725 Free PMC article. Clinical Trial.
A phase II trial of paclitaxel plus biweekly cetuximab for patients with recurrent or metastatic head and neck cancer previously treated with both platinum-based chemotherapy and anti-PD-1 antibody.
Koyama T, Kiyota N, Boku S, Imamura Y, Shibata N, Satake H, Tanaka K, Hayashi H, Onoe T, Asada Y, Yamazaki T, Nose T, Ohata S, Nagatani Y, Kimbara S, Funakoshi Y, Teshima M, Shinomiya H, Minami H. Koyama T, et al. Among authors: boku s. ESMO Open. 2024 Jun;9(6):103476. doi: 10.1016/j.esmoop.2024.103476. Epub 2024 Jun 3. ESMO Open. 2024. PMID: 38833968 Free PMC article. Clinical Trial.
Randomized Phase III Trial of Ramucirumab Beyond Progression Plus Irinotecan in Patients With Ramucirumab-Refractory Advanced Gastric Cancer: RINDBeRG Trial.
Sakai D, Kadowaki S, Kawabata R, Hara H, Satake H, Takahashi M, Takeno A, Imai H, Minashi K, Kawakami T, Boku S, Matsuyama J, Sakamoto Y, Sawada K, Kataoka M, Kawakami H, Shimokawa T, Boku N, Satoh T. Sakai D, et al. Among authors: boku s. J Clin Oncol. 2025 Jul;43(19):2196-2207. doi: 10.1200/JCO.24.01119. Epub 2025 May 23. J Clin Oncol. 2025. PMID: 40408613 Free PMC article. Clinical Trial.
Landscape Analysis of CLDN18 Expression and Isoform Distribution in Solid Tumors: Insights From MONSTAR-SCREEN-2 Study.
Hashimoto T, Iida N, Nakamura Y, Nonomura N, Morizane C, Iwata H, Okano S, Yamagami W, Yamazaki N, Kadowaki S, Ueno M, Boku S, Oki E, Komatsu Y, Yuki S, Makiyama A, Ogata T, Takahashi N, Okano N, Nishina T, Sakamoto N, Kuwata T, Yamashita R, Shibuki T, Imai M, Fujisawa T, Bando H, Shitara K, Yoshino T. Hashimoto T, et al. Among authors: boku s. Cancer Sci. 2025 Aug;116(8):2218-2231. doi: 10.1111/cas.70100. Epub 2025 Jun 2. Cancer Sci. 2025. PMID: 40455642 Free PMC article.
The SCRUM-MONSTAR Cancer-Omics Ecosystem: Striving for a Quantum Leap in Precision Medicine.
Hashimoto T, Nakamura Y, Fujisawa T, Imai M, Shibuki T, Iida N, Ozaki H, Nonomura N, Morizane C, Iwata H, Okano S, Yamagami W, Yamazaki N, Kadowaki S, Taniguchi H, Ueno M, Boku S, Oki E, Komatsu Y, Yuki S, Makiyama A, Otsuka T, Hara H, Okano N, Nishina T, Sakamoto Y, Miki I, Kobayashi S, Yuda J, Kageyama SI, Nagamine M, Sakashita S, Sakamoto N, Yamashita R, Koga Y, Bando H, Ishii G, Kuwata T, Park WY, Ohtsu A, Yoshino T. Hashimoto T, et al. Among authors: boku s. Cancer Discov. 2024 Nov 1;14(11):2243-2261. doi: 10.1158/2159-8290.CD-24-0206. Cancer Discov. 2024. PMID: 39023403 Free PMC article.
Novel ERBB2 Variant Potentially Associated with Resistance against Anti-HER2 Monoclonal Antibody-Based Therapy in ERBB2-Amplified Metastatic Colorectal Cancer.
Iida N, Imai M, Okamoto W, Kato T, Esaki T, Kato K, Komatsu Y, Yuki S, Masuishi T, Nishina T, Ebi H, Taniguchi H, Nonomura N, Sunakawa Y, Shiozawa M, Yamazaki K, Boku S, Bando H, Shiraishi Y, Kobayashi M, Goto H, Sato A, Fujii S, Yoshino T, Nakamura Y. Iida N, et al. Among authors: boku s. Clin Cancer Res. 2024 Sep 13;30(18):4167-4178. doi: 10.1158/1078-0432.CCR-24-1023. Clin Cancer Res. 2024. PMID: 39163021 Free PMC article.
Prediction of postoperative delirium by blood metabolome analysis.
Arai N, Sugiura Y, Nakajima S, Wada M, Moriyama S, Mimura Y, Niinomi K, Takayama K, Maeda R, Kitada S, Fagarasan S, Tajima M, Boku S, Takebayashi M, Kato J, Kitago M, Kitagawa Y, Takahashi T, Shimizu H, Uchida H, Suematsu M, Mimura M, Noda Y. Arai N, et al. Among authors: boku s. J Psychiatr Res. 2025 Apr;184:500-514. doi: 10.1016/j.jpsychires.2025.03.028. Epub 2025 Mar 21. J Psychiatr Res. 2025. PMID: 40153971
A multisite observational real-world study on the effectiveness of repetitive transcranial magnetic stimulation therapy for patients with treatment-resistant depression in Japan.
Matsuda Y, Kito S, Hiraki F, Izuno T, Yoshida K, Nakamura M, Kodaka F, Yamazaki R, Taruishi N, Imazu S, Kanazawa T, Mekata T, Moriyama S, Wada M, Nakajima S, Sawada K, Watanabe S, Takahashi S, Toi Y, Hayashi D, Igarashi S, Fujiyama K, Ikeda S, Tateishi H, Kojima R, Sato K, Boku S, Takebayashi M, Ogura M, Takaya A, Endo K, Kita A, Arai H, Kamimura H, Matsuo K, Denda K, Yamashiro S, Yoshioka D, Kizaki J, Mimura M, Noda Y. Matsuda Y, et al. Among authors: boku s. Psychiatry Res. 2024 Dec;342:116263. doi: 10.1016/j.psychres.2024.116263. Epub 2024 Nov 10. Psychiatry Res. 2024. PMID: 39549597 Free article.
197 results